Russell Investments Group, Ltd. Vaxart, Inc. Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$6.67 - $9.8 $219,249 - $322,135	-32,871 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$5.06 - $10.78 $60,719 - $129,359	-12,000 Reduced 26.74%	32,871 $246,000
Q1 2021 May 10, 2021	BUY	$5.64 - $23.33 $253,072 - $1.05 Million	44,871 New	44,871 $270,000
Q4 2020 Feb 08, 2021	SELL	$3.5 - $7.98 $170,684 - $389,160	-48,767 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$1.68 - $8.85 $81,928 - $431,587	48,767 New	48,767 $431,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.